|
|
August 1999 Tamoxifen vs. Raloxifene: A Major New Study To Reduce Breast Cancer Risk The Johns Hopkins Breast Center is joining more than 500 centers across the United States and Canada in recruiting volunteers for the Study of Tamoxifen and Raloxifene, or STAR, one of the largest breast cancer prevention studies ever to be undertaken. Up to 22,000 women will take part in the study.Read full article
|
Research Review A Trojan Horse to Fight Cancer Boosting the Immune System to Fight Cancer Growing "Stem Cells" Outside the Body Depression Linked to Lack of Estrogen
Complementary Approaches Fish Consumption Reduces Cancer RiskBreastfeeding Tied to Lower Breast Cancer Risk
|
|
|
|
 |
Quality Corner |